Ποια είναι η τιμή για GeneReach Biotechnology Corp. (4171)

Η τιμή για GeneReach Biotechnology Corp. (4171) είναι $0.54853323

Ποια είναι η κεφαλαιοποίηση αγοράς για GeneReach Biotechnology Corp. (4171)

Η κεφαλαιοποίηση αγοράς για GeneReach Biotechnology Corp. (4171) είναι $31.43M

GeneReach Biotechnology Corp. (4171) Τιμή και Κεφαλαιοποίηση Αγοράς

GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.

Η τιμή για 4171	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$92,500.74 $31.43M	NVDA	$5.301T	+16,863,188.18%
$80,861.52 $31.43M	AAPL	$4.634T	+14,741,307.10%
$72,295.48 $31.43M	GOOG	$4.143T	+13,179,680.97%
$62,634.96 $31.43M	MSFT	$3.589T	+11,418,525.66%
$49,854.07 $31.43M	AMZN	$2.857T	+9,088,514.97%

Η τιμή για 4171

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$92,500.74 $31.43M